Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting

被引：0
|
作者：
Nicolini, Gabriele
Terzano, Claudio
Cremonesi, Giovanni
Girbino, Giuseppe
Ingrassia, Eleonora
Marsico, Serafino
Allegra, Luigi
机构：
[1] Chiesi Farmaceut, Med Affairs, Parma, Italy
[2] Univ Roma La Sapienza, Resp Dis Unit, I-00185 Rome, Italy
[3] Univ Messina, Inst Resp Med, Messina, Italy
[4] Univ Naples 2, Azienda Osped Monaldi, Dept Resp Med, Naples, Italy
[5] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Thoracopulm Dept, Milan, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Asthma; -; management; Longitudinal study; Monitoring;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
609
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A retrospective, observational study comparing outcomes of asthma treatment with fixed combinations of inhaled corticosteroid and long-acting a2-agonist (ICS/LABA) in real-life practice
    Thomas, M.
    Von Ziegenweidt, J.
    Wiren, A.
    Stahl, E.
    Price, D.
    VALUE IN HEALTH, 2007, 10 (06) : A240 - A241
  • [32] Dupilumab leads to sustained improvement of asthma control in real-life severe asthmatics
    Renner, A.
    Marth, K.
    Patocka, K.
    Idzko, M.
    Pohl, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [33] Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review
    Saeed Noibi
    Ahmed Mohy
    Raef Gouhar
    Fadel Shaker
    Tamara Lukic
    Hamdan Al-Jahdali
    BMC Public Health, 20
  • [34] Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review
    Noibi, Saeed
    Mohy, Ahmed
    Gouhar, Raef
    Shaker, Fadel
    Lukic, Tamara
    Al-Jahdali, Hamdan
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [35] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Koczulla, A.
    Akyildiz, B.
    Slawinska, R.
    Martini, M.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S35
  • [36] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [37] REAL-LIFE EFFECTS OF SWITCHING LABA/ICS DRY POWDER INHALERS TO FORMOTEROL/FLUTICASONE IN KOREAN ASTHMA PATIENTS: THE TRANSFFORM STUDY
    Price, D.
    Park, H. S.
    Yoon, D.
    Lee, H. Y.
    Ming, S. Wan Yau
    Van Boven, J. F.
    RESPIROLOGY, 2016, 21 : 22 - 22
  • [38] Efficacy and Safety of a Fixed Combination Extrafine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI Treatment Compared to Fixed Combination BDP/FF in Patients with Uncontrolled Asthma on Medium Dose ICS/LABA: The TRIMARAN Study
    Paggiaro, P.
    Kuna, P.
    Kots, M.
    Corre, S.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    Virchow, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [39] Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma-The NEXT-Step Study
    Bakakos, Petros
    Chatziapostolou, Panagiotis
    Katerelos, Panos
    Efstathopoulos, Petros
    Korkontzelou, Aliki
    Katsaounou, Paraskevi
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [40] Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Idzko, Marco
    Pohl, Wolfgang
    ALLERGY, 2020, 75 (12) : 3272 - 3275
12345